AK Medical Holdings Limited

SEHK:1789 Voorraadrapport

Marktkapitalisatie: HK$5.6b

AK Medical Holdings Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Zhijiang Li

Algemeen directeur

CN¥1.1m

Totale compensatie

Percentage CEO-salaris74.9%
Dienstverband CEO9.3yrs
Eigendom CEO45.0%
Management gemiddelde ambtstermijn3.9yrs
Gemiddelde ambtstermijn bestuur8.8yrs

Recente managementupdates

It's Unlikely That Shareholders Will Increase AK Medical Holdings Limited's (HKG:1789) Compensation By Much This Year

Jun 11
It's Unlikely That Shareholders Will Increase AK Medical Holdings Limited's (HKG:1789) Compensation By Much This Year

Recent updates

AK Medical Holdings Limited (HKG:1789) Not Flying Under The Radar

Nov 18
AK Medical Holdings Limited (HKG:1789) Not Flying Under The Radar

AK Medical Holdings Limited's (HKG:1789) Intrinsic Value Is Potentially 92% Above Its Share Price

Aug 30
AK Medical Holdings Limited's (HKG:1789) Intrinsic Value Is Potentially 92% Above Its Share Price

Why We're Not Concerned Yet About AK Medical Holdings Limited's (HKG:1789) 25% Share Price Plunge

Jun 20
Why We're Not Concerned Yet About AK Medical Holdings Limited's (HKG:1789) 25% Share Price Plunge

It's Unlikely That Shareholders Will Increase AK Medical Holdings Limited's (HKG:1789) Compensation By Much This Year

Jun 11
It's Unlikely That Shareholders Will Increase AK Medical Holdings Limited's (HKG:1789) Compensation By Much This Year

Returns On Capital At AK Medical Holdings (HKG:1789) Paint A Concerning Picture

May 27
Returns On Capital At AK Medical Holdings (HKG:1789) Paint A Concerning Picture

We Think AK Medical Holdings (HKG:1789) Can Stay On Top Of Its Debt

May 08
We Think AK Medical Holdings (HKG:1789) Can Stay On Top Of Its Debt

Investors Appear Satisfied With AK Medical Holdings Limited's (HKG:1789) Prospects

Apr 21
Investors Appear Satisfied With AK Medical Holdings Limited's (HKG:1789) Prospects

AK Medical Holdings Limited (HKG:1789) Analysts Are Reducing Their Forecasts For This Year

Apr 01
AK Medical Holdings Limited (HKG:1789) Analysts Are Reducing Their Forecasts For This Year

AK Medical Holdings' (HKG:1789) Returns On Capital Not Reflecting Well On The Business

Jan 22
AK Medical Holdings' (HKG:1789) Returns On Capital Not Reflecting Well On The Business

Shareholders Should Be Pleased With AK Medical Holdings Limited's (HKG:1789) Price

Jan 04
Shareholders Should Be Pleased With AK Medical Holdings Limited's (HKG:1789) Price

AK Medical Holdings (HKG:1789) Seems To Use Debt Rather Sparingly

Dec 12
AK Medical Holdings (HKG:1789) Seems To Use Debt Rather Sparingly

A Look At The Fair Value Of AK Medical Holdings Limited (HKG:1789)

Nov 09
A Look At The Fair Value Of AK Medical Holdings Limited (HKG:1789)

AK Medical Holdings (HKG:1789) Could Be Struggling To Allocate Capital

Sep 20
AK Medical Holdings (HKG:1789) Could Be Struggling To Allocate Capital

AK Medical Holdings (HKG:1789) Could Easily Take On More Debt

Sep 03
AK Medical Holdings (HKG:1789) Could Easily Take On More Debt

Investors Could Be Concerned With AK Medical Holdings' (HKG:1789) Returns On Capital

Jun 07
Investors Could Be Concerned With AK Medical Holdings' (HKG:1789) Returns On Capital

Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)

May 18
Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)

Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)

Feb 13
Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)

Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)

Nov 10
Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)

Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)

Sep 29
Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)

Be Wary Of AK Medical Holdings (HKG:1789) And Its Returns On Capital

Aug 04
Be Wary Of AK Medical Holdings (HKG:1789) And Its Returns On Capital

Are Investors Undervaluing AK Medical Holdings Limited (HKG:1789) By 44%?

Jun 25
Are Investors Undervaluing AK Medical Holdings Limited (HKG:1789) By 44%?

There Are Reasons To Feel Uneasy About AK Medical Holdings' (HKG:1789) Returns On Capital

Apr 11
There Are Reasons To Feel Uneasy About AK Medical Holdings' (HKG:1789) Returns On Capital

Capital Allocation Trends At AK Medical Holdings (HKG:1789) Aren't Ideal

Oct 08
Capital Allocation Trends At AK Medical Holdings (HKG:1789) Aren't Ideal

Estimating The Intrinsic Value Of AK Medical Holdings Limited (HKG:1789)

Sep 20
Estimating The Intrinsic Value Of AK Medical Holdings Limited (HKG:1789)

Analysts Are More Bearish On AK Medical Holdings Limited (HKG:1789) Than They Used To Be

Jul 27
Analysts Are More Bearish On AK Medical Holdings Limited (HKG:1789) Than They Used To Be

I Built A List Of Growing Companies And AK Medical Holdings (HKG:1789) Made The Cut

Jul 19
I Built A List Of Growing Companies And AK Medical Holdings (HKG:1789) Made The Cut

AK Medical Holdings Limited (HKG:1789) Shares Could Be 39% Below Their Intrinsic Value Estimate

Jun 16
AK Medical Holdings Limited (HKG:1789) Shares Could Be 39% Below Their Intrinsic Value Estimate

The Returns On Capital At AK Medical Holdings (HKG:1789) Don't Inspire Confidence

Jun 01
The Returns On Capital At AK Medical Holdings (HKG:1789) Don't Inspire Confidence

Analyse CEO-vergoeding

Hoe is Zhijiang Li's beloning veranderd ten opzichte van AK Medical Holdings's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

CN¥189m

Mar 31 2024n/an/a

CN¥185m

Dec 31 2023CN¥1mCN¥814k

CN¥182m

Sep 30 2023n/an/a

CN¥197m

Jun 30 2023n/an/a

CN¥211m

Mar 31 2023n/an/a

CN¥208m

Dec 31 2022CN¥972kCN¥806k

CN¥205m

Sep 30 2022n/an/a

CN¥156m

Jun 30 2022n/an/a

CN¥107m

Mar 31 2022n/an/a

CN¥100m

Dec 31 2021CN¥913kCN¥800k

CN¥93m

Sep 30 2021n/an/a

CN¥178m

Jun 30 2021n/an/a

CN¥263m

Mar 31 2021n/an/a

CN¥288m

Dec 31 2020CN¥524kCN¥430k

CN¥314m

Sep 30 2020n/an/a

CN¥307m

Jun 30 2020n/an/a

CN¥300m

Mar 31 2020n/an/a

CN¥284m

Dec 31 2019CN¥1mCN¥779k

CN¥267m

Sep 30 2019n/an/a

CN¥235m

Jun 30 2019n/an/a

CN¥203m

Mar 31 2019n/an/a

CN¥174m

Dec 31 2018CN¥1mCN¥764k

CN¥145m

Sep 30 2018n/an/a

CN¥136m

Jun 30 2018n/an/a

CN¥127m

Mar 31 2018n/an/a

CN¥116m

Dec 31 2017CN¥776kCN¥765k

CN¥105m

Compensatie versus markt: De totale vergoeding ($USD 150.05K ) Zhijiang } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 481.54K ).

Compensatie versus inkomsten: De vergoeding van Zhijiang is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Zhijiang Li (56 yo)

9.3yrs

Tenure

CN¥1,087,000

Compensatie

Mr. Zhijiang Li serves as Chairman and Chief Executive Officer at AK Medical Holdings Limited. Mr. Li is responsible for the overall strategic planning and development of at AK Medical Holdings Limited. Mr...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Zhijiang Li
Chairman & CEOno dataCN¥1.09m45%
HK$ 2.5b
Bin Mo Zhang
Senior VP & Executive Director8.6yrsCN¥193.00k0.90%
HK$ 50.4m
Chaoyang Zhang
Senior VP & Executive Director8.6yrsCN¥1.19m5.24%
HK$ 292.9m
Xiaohong Zhao
Executive Directorno dataCN¥1.57m0.19%
HK$ 10.6m
Kun Liang
Chief Financial Officer3.9yrsgeen gegevensgeen gegevens
Hanzhong Sun
Vice President of Human Resources3.5yrsgeen gegevensgeen gegevens
Rongkun Ma
Company Secretaryless than a yeargeen gegevensgeen gegevens

3.9yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 1789 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.9 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Zhijiang Li
Chairman & CEO9.3yrsCN¥1.09m45%
HK$ 2.5b
Bin Mo Zhang
Senior VP & Executive Director9.3yrsCN¥193.00k0.90%
HK$ 50.4m
Chaoyang Zhang
Senior VP & Executive Director9.3yrsCN¥1.19m5.24%
HK$ 292.9m
Xiaohong Zhao
Executive Director8.8yrsCN¥1.57m0.19%
HK$ 10.6m
David Wang
Non-Executive Director8.8yrsgeen gegevensgeen gegevens
Chi Mo Kong
Independent Non-Executive Director7yrsCN¥178.00kgeen gegevens
Shu Wing Li
Independent Non-Executive Director7yrsCN¥178.00kgeen gegevens
Wei Gao
Independent Non-Executive Directorless than a yeargeen gegevensgeen gegevens

8.8yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 1789 wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.8 jaar).